Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Suspected menopause nutraceutical-induced eosinophilic ascites: a rare clinical presentation.

Created on 02 Sep 2026

Authors

Gemma Vicens-Novell, Alejandro Alonso-Galera, Rosa Muñoz-Cano, Joaquín Sáez-Peñataro

Published in

BMJ case reports. Volume 19. Issue 9. Sep 01, 2026. Epub Sep 01, 2026.

Abstract

A middle-aged woman presented with a 2-month history of ascites without associated symptoms. She reported taking no regular medication, except for a menopause supplement for the preceding 4 months. Initial blood investigation revealed marked peripheral eosinophilia (49%) but was otherwise unremarkable. Analysis of the ascitic fluid demonstrated a predominance of eosinophils (90%) with no evidence of malignancy.Abdominal ultrasonography identified liver lesions; however, malignancy was excluded by CT. Gastroscopy findings were normal and biopsies showed no malignant features. Tumour markers were within normal limits, except for an elevated CA-125 level. Autoimmune and infectious causes were excluded and no other underlying cause for the ascites was identified.Following discontinuation of the dietary supplement, both the ascites and eosinophilia resolved within a month without specific treatment. The temporal relationship and subsequent clinical improvement after withdrawal highlight the supplement as a possible contributing factor to eosinophilic ascites and hypereosinophilia.

PMID:
42680502
Bibliographic data and abstract were imported from PubMed on 02 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement